Papaluca T - Search Results

1

A costing analysis of a state-wide, nurse-led hepatitis C treatment model in prison.

Palmer A, Papaluca T, Stoové M, Winter R, Pedrana A, Hellard M, Wilson D, Thompson A, Scott N; EC Victoria Partnership. Palmer A, et al. Among authors: papaluca t. Int J Drug Policy. 2021 Aug;94:103203. doi: 10.1016/j.drugpo.2021.103203. Epub 2021 Mar 18. Int J Drug Policy. 2021. PMID: 33744667

2

Cyclophosphamide-associated enteritis: A rare association with severe enteritis.

Yang LS, Cameron K, Papaluca T, Basnayake C, Jackett L, McKelvie P, Goodman D, Demediuk B, Bell SJ, Thompson AJ. Yang LS, et al. Among authors: papaluca t. World J Gastroenterol. 2016 Oct 21;22(39):8844-8848. doi: 10.3748/wjg.v22.i39.8844. World J Gastroenterol. 2016. PMID: 27818600 Free PMC article.

3

Patient-centred care for cirrhosis: a key role for chronic disease management.

Papaluca T, Thompson AJ. Papaluca T, et al. Med J Aust. 2018 Sep 1;209(7):296-297. doi: 10.5694/mja18.00754. Med J Aust. 2018. PMID: 30257630 No abstract available.

4

Outcomes of treatment for hepatitis C in prisoners using a nurse-led, statewide model of care.

Papaluca T, McDonald L, Craigie A, Gibson A, Desmond P, Wong D, Winter R, Scott N, Howell J, Doyle J, Pedrana A, Lloyd A, Stoove M, Hellard M, Iser D, Thompson A. Papaluca T, et al. J Hepatol. 2019 May;70(5):839-846. doi: 10.1016/j.jhep.2019.01.012. Epub 2019 Jan 14. J Hepatol. 2019. PMID: 30654067

5

Scale-up of hepatitis C treatment in prisons is key to national elimination.

Papaluca T, Hellard ME, Thompson AJV, Lloyd AR. Papaluca T, et al. Med J Aust. 2019 May;210(9):391-393.e1. doi: 10.5694/mja2.50140. Epub 2019 Apr 9. Med J Aust. 2019. PMID: 30968417 No abstract available.

6

Long-Term Impact of Direct-Acting Antiviral Agent Therapy in HCV Cirrhosis: Critical Review.

Fehily SR, Papaluca T, Thompson AJ. Fehily SR, et al. Among authors: papaluca t. Semin Liver Dis. 2019 Jul;39(3):341-353. doi: 10.1055/s-0039-1685538. Epub 2019 Apr 30. Semin Liver Dis. 2019. PMID: 31041785 Review.

7

Retreatment with elbasvir, grazoprevir, sofosbuvir ± ribavirin is effective for GT3 and GT1/4/6 HCV infection after relapse.

Papaluca T, Sinclair M, Gow P, Pianko S, Sievert W, Arachchi N, Cameron K, Bowden S, O'Keefe J, Doyle J, Stoove M, Hellard M, Iser D, Thompson A. Papaluca T, et al. Liver Int. 2019 Dec;39(12):2285-2290. doi: 10.1111/liv.14201. Epub 2019 Aug 13. Liver Int. 2019. PMID: 31355968 Clinical Trial.

8

Prevalence of baseline HCV NS5A resistance associated substitutions in genotype 1a, 1b and 3 infection in Australia.

Papaluca T, O'Keefe J, Bowden S, Doyle JS, Stoove M, Hellard M, Thompson AJ. Papaluca T, et al. J Clin Virol. 2019 Nov;120:84-87. doi: 10.1016/j.jcv.2019.09.011. Epub 2019 Oct 3. J Clin Virol. 2019. PMID: 31606586

9

Effective prison-based treatment and linkage to care after release.

Papaluca TJ, Tambakis G, Iser D, Thompson AJ. Papaluca TJ, et al. Lancet Infect Dis. 2019 Nov;19(11):1171. doi: 10.1016/S1473-3099(19)30536-5. Lancet Infect Dis. 2019. PMID: 31657780 No abstract available.

10

Efficacy and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus (HCV) NS5A-Inhibitor Experienced Patients With Difficult to Cure Characteristics.

Papaluca T, Roberts SK, Strasser SI, Stuart KA, Farrell G, MacQuillan G, Dore GJ, Wade AJ, George J, Hazeldine S, O'Beirne J, Wigg A, Fisher L, McGarity B, Sawhney R, Sinclair M, Thomas J, Valiozis I, Weltman M, Wilson M, Woodward A, Ahlenstiel G, Haque M, Levy M, Prewett E, Sievert W, Sood S, Tse E, Valaydon Z, Bowden S, Douglas M, New K, O'Keefe J, Hellard M, Doyle J, Stoove M, Thompson AJ. Papaluca T, et al. Clin Infect Dis. 2021 Nov 2;73(9):e3288-e3295. doi: 10.1093/cid/ciaa1318. Clin Infect Dis. 2021. PMID: 32887983

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page